SARS-2 Coronavirus-Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism?

Semin Thromb Hemost. 2020 Oct;46(7):777-780. doi: 10.1055/s-0040-1712155. Epub 2020 May 12.
No abstract available

Publication types

  • Review

MeSH terms

  • Arterial Occlusive Diseases / diagnosis*
  • Arterial Occlusive Diseases / etiology
  • Arterial Occlusive Diseases / pathology
  • Arterial Occlusive Diseases / prevention & control
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / blood*
  • Cytokine Release Syndrome / blood
  • Cytokine Release Syndrome / complications
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Pandemics*
  • Pneumonia, Viral / blood*
  • Pulmonary Artery* / pathology
  • Pulmonary Embolism / diagnosis*
  • Pulmonary Embolism / etiology
  • Pulmonary Embolism / pathology
  • Pulmonary Veins* / pathology
  • SARS-CoV-2
  • Thrombophilia / drug therapy
  • Thrombophilia / etiology
  • Thrombosis / diagnosis*
  • Thrombosis / etiology
  • Thrombosis / pathology
  • Thrombosis / prevention & control
  • Thrombotic Microangiopathies / blood
  • Thrombotic Microangiopathies / etiology
  • Thrombotic Microangiopathies / physiopathology
  • Thrombotic Microangiopathies / prevention & control
  • Venous Thrombosis / diagnosis
  • Venous Thrombosis / etiology
  • Venous Thrombosis / prevention & control

Substances

  • Fibrinolytic Agents